Pfizer Zeldox
Executive Summary
European mutual recognition procedure delayed for antipsychotic ziprasidone, company said Dec. 21. Pfizer will supplement the European filing with data from its NDA. Zeldox is "approvable" at FDA in an oral formulation, and a FDA advisory committee will review the intramuscular formulation Feb. 15 (1"The Pink Sheet" Dec. 11, 2000, In Brief)